Stromatt Scott C
Insider CIK 1679975 · APVO Chief Medical Officer and SVP
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 16,269 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 4,823 | $1.57 | $7.6K | 216,183 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2019-03-01 | 2019-03-04 | 16,269 | — | $0 | 221,006 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-09 | 2018-03-13 | 13,892 | — | $0 | 16,269 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-03-09 | 2018-03-13 | 67,400 | — | $0 | 67,400 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-09 | 2018-03-13 | 13,892 | — | $0 | 204,737 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 16,269 | — | $0 | 30,161 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 16,269 | — | $0 | 190,845 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-02-03 | 2018-02-06 | 27,381 | — | $0 | 46,430 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-02-03 | 2018-02-06 | 27,381 | — | $0 | 174,576 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-08-01 | 2017-08-03 | 78,123 | — | $0 | 73,811 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-08-01 | 2017-08-03 | 78,123 | — | $0 | 147,195 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 33,700 | — | $0 | 33,700 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-10 | 2017-03-13 | 24,836 | — | $0 | 151,934 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-10 | 2017-03-13 | 6,570 | $1.78 | $11.7K | 69,072 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-10 | 2017-03-13 | 24,836 | — | $0 | 75,642 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-09 | 2017-03-13 | 13,902 | — | $0 | 176,770 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-09 | 2017-03-13 | 13,902 | — | $0 | 54,484 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-09 | 2017-03-13 | 3,678 | $1.80 | $6.6K | 50,806 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-03-01 | 2017-03-13 | 16,269 | — | $0 | 190,672 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-03-01 | 2017-03-13 | 16,269 | — | $0 | 45,894 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2017-03-01 | 2017-03-13 | 5,312 | $2.02 | $10.7K | 40,582 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-02-24 | 2017-02-27 | 33,700 | — | $0 | 236,580 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-02-03 | 2017-02-08 | 27,381 | — | $0 | 206,941 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-02-03 | 2017-02-08 | 27,381 | — | $0 | 29,625 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 54,762 | — | $0 | 54,762 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 78,124 | — | $0 | 78,124 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-09-27 | 78,123 | — | $0 | 234,322 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-09-27 | 54,762 | — | $0 | 54,762 | SEC↗ |